Phoenix, AZ (PRWEB) June 18, 2012
ThermoLife International, LLC (ThermoLife) announced today that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No. 8,178,572 (the ‘572 patent) on May 15, 2012 for ThermoLife’s novel use of amino acid nitrates. The patented method uses a nitrate or nitrite of Arginine, Agmatine, Beta Alanine, Citrulline, Creatine, Glutamine, L-Histidine, Isoleucine, Leucine, Norvaline, Ornithine, or Valine to increase their vasodilative characteristics in individuals.
ThermoLife has a long history of developing innovative and proven products and processes. With the addition of the ‘572 patent, ThermoLife has been awarded seven U.S. Patents covering more than 20 various compounds and methods of use, and still has many pending applications in the pipeline and new technologies at various stages of development.
These patents protect ThermoLife’s innovative and proven products and methods, as well as validate ThermoLife’s market leadership in new dietary ingredient research. These patents also allow ThermoLife to continue building confidence with its licensing partners and give consumers and companies that work with ThermoLife assurance that they are buying one-of-a-kind products that they cannot get elsewhere.
Founded in 1998, ThermoLife is dedicated to developing real products and methods that work. ThermoLife is a leading manufacturer in the sports nutrition and supplement industry. ThermoLife is committed to developing only the purest, most effective, and innovative products. For more information about ThermoLife and its patents, or to license any of ThermoLife’s patented ingredients contact Ron Kramer at Ron(at)ThermoLife(dot)com